Nordea Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.91M | Buy |
|
|||||
|
2025
Q2 | $6.11M | Buy |
|
|||||
|
2025
Q1 | $4.57M | Buy |
|
|||||
|
2024
Q4 | $4.95M | Buy |
|
|||||
|
2024
Q3 | $4.06M | Sell |
|
|||||
|
2024
Q2 | $4.45M | Sell |
|
|||||
|
2024
Q1 | $5.94M | Sell |
|
|||||
|
2023
Q4 | $18.5M | Sell |
|
|||||
|
2023
Q3 | $12.5M | Sell |
|
|||||
|
2023
Q2 | $14.5M | Buy |
|
|||||
|
2023
Q1 | $11M | Sell |
|
|||||
|
2022
Q4 | $9.76M | Sell |
|
|||||
|
2022
Q3 | $10.2M | Sell |
|
|||||
|
2022
Q2 | $8.89M | Buy |
|
|||||
|
2022
Q1 | $15M | Buy |
|
|||||
|
2021
Q4 | $14.2M | Sell |
|
|||||
|
2021
Q3 | $10.3M | Buy |
|
|||||
|
2021
Q2 | $11.2M | Buy |
|
|||||
|
2021
Q1 | $400K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $27K | Hold |
|
|||||
|
2018
Q4 | $16K | Buy |
|